RecruitingNot ApplicableNCT04993469

Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery


Sponsor

University Hospital, Ghent

Enrollment

200 participants

Start Date

May 27, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria5

  • Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations
  • Patient age ≥ 18 years
  • Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery
  • Fit for operation, based on the surgeon's expert opinion
  • Patient is able and willing to attend the follow-up consultations

Exclusion Criteria5

  • Absence of signed written informed consent and thus a patient unwilling to participate.
  • Patient age < 18 years
  • Cisgender patients
  • Patients unfit for operation
  • Patient declares that it will be impossible for him to attend the follow-up consultations

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSemmes-Weinstein monofilament testing and questionnaires

Semmes-Weinstein test for the assessment of genital sensation Battery of questionnaires assessing sexual function, voiding function, quality of life and patient satisfaction


Locations(1)

University Hospital Ghent

Ghent, East-Flanders, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04993469


Related Trials